Company Profile

TransEnterix, Inc. is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company's ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera. The system features advanced technology to enable surgeons with haptic feedback and the ability to move the camera through eye movement. The system replicates laparoscopic motion and integrates three-dimensional high definition (3DHD) vision technology. The ALF-X System also offers responsible economics to hospitals by offering robotic technology with reusable instruments. The SurgiBot System is designed as a single-incision, patient-side robotic-assisted surgery system. The Company also develops and manufactures laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

23/08/24	Asensus Surgical, Inc.(NYSEAM:ASXC) dropped from S&P Global BMI Index	CI
23/08/24	Asensus Surgical, Inc.(NYSEAM:ASXC) dropped from S&P TMI Index	CI

23/08/24	Asensus Surgical, Inc.(NYSEAM:ASXC) dropped from S&P Global BMI Index	CI
23/08/24	Asensus Surgical, Inc.(NYSEAM:ASXC) dropped from S&P TMI Index	CI
22/08/24	Asensus Surgical Shares Cease Trading as Acquisition by Karl Storz Closes	MT
22/08/24	Asensus Surgical, Inc. Announces Board and Committee Changes	CI
22/08/24	KARL STORZ Endoscopy-America, Inc. completed the acquisition of Asensus Surgical, Inc..	CI
20/08/24	Asensus Surgical Shares Jump After Shareholders Approve Karl Storz Deal	MT
13/08/24	Asensus Surgical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
13/08/24	Asensus Surgical, Inc., Q2 2024 Earnings Call, Aug 13, 2024
13/08/24	Earnings Flash (ASXC) ASENSUS SURGICAL Posts Q2 Revenue $2.2M, vs. Street Est of $1.23M	MT
13/08/24	Earnings Flash (ASXC) ASENSUS SURGICAL Reports Q2 Loss $-0.07, vs. Street Est of $-0.05	MT
23/07/24	Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in Urology	CI
16/07/24	Asensus Surgical, Inc. Announces LKH-Universitätsklinikum Graz Hospital in Austria to Initiate Senhance Surgery Program	CI
07/06/24	Sector Update: Health Care Stocks Higher Late Afternoon	MT

04/04/24	HC Wainwright Downgrades Asensus Surgical to Neutral From Buy, Adjusts PT to $0.35 From $2	MT
16/11/23	Cantor Fitzgerald Downgrades Asensus Surgical to Neutral From Overweight	MT
06/03/23	HC Wainwright Adjusts Price Target on Asensus Surgical to $2 From $3, Keeps Buy Rating	MT
08/09/22	Cantor Fitzgerald Initiates Asensus Surgical at Overweight With $1.50 Price Target	MT
26/05/21	Asensus Surgical : HC Wainwright Starts Asensus Surgical at Buy With $4 Price Target	MT

22/08/24	Asensus Surgical Announces Closing of Acquisition by KARL STORZ	AQ
13/08/24	Asensus Surgical: Q2 Earnings Snapshot	AQ
13/08/24	Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2024	AQ
08/08/24	Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 13, 2024	AQ
07/08/24	Asensus Surgical 2024 Special Meeting of Stockholders Is Adjourned	AQ

23/06/20	Transenterix : TransEnterix kündigt an, dass das Sana Klinikum Offenbach das Senhance Surgical System einsetzen wird
31/10/19	TransEnterix : meldet Plan für Aktienzusammenlegung
23/03/17	TransEnterix : gibt die Ausdehnung des Operationssystems Senhance™ auf die robotergestützte Reparatur von Hernien bekannt
24/02/17	TransEnterix : schließt Verkauf des chirurgischen Operationssystems Senhance™ in Deutschland ab
14/02/17	TransEnterix : gibt erste klinische Nutzung des Robotersystems Senhance™ für chirurgische Eingriffe in Frankreich bekannt

SAFESTITCH MEDICAL Stock OTC Bulletin Board

Stocks

Medical Equipment, Supplies & Distribution

Latest news : SAFESTITCH MEDICAL

Analysts' recommendations: SAFESTITCH MEDICAL

Press Releases: SAFESTITCH MEDICAL

News in other languages: SAFESTITCH MEDICAL

Managers and Directors: SAFESTITCH MEDICAL

Other Medical Equipment, Supplies & Distribution

Company Profile

Manager	Title	Age	Since
Anthony Fernando CEO	Chief Executive Officer	54	08/11/2019
Ken Nicolosi CTO	Chief Tech/Sci/R&D Officer	-	01/07/2020
Motti Frimer CTO	Chief Tech/Sci/R&D Officer	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ABBOTT LABORATORIES	-0.79%	+1.61%	-16.23%	+5.18%	193B
MEDTRONIC PLC	-0.73%	+1.33%	-2.60%	+11.08%	117B
CENCORA, INC.	-0.41%	-3.84%	+6.73%	+73.62%	59.89B
HOYA CORPORATION	-0.15%	+1.35%	+34.35%	+70.45%	56.01B
BECTON, DICKINSON AND COMPANY	-0.71%	+1.37%	-7.07%	-33.92%	49.96B
DEXCOM, INC.	-1.10%	+1.27%	+9.65%	-17.67%	33.87B
MEDLINE INC.	-2.41%	+3.16%	-	-	31.36B
TERUMO CORPORATION	-2.37%	-1.52%	-8.23%	+24.07%	24.77B
WEST PHARMACEUTICAL SERVICES, INC.	-0.80%	-1.57%	+40.78%	-11.77%	24.59B
Average	-1.05%	+1.57%	+7.17%	+15.13%	65.53B
Weighted average by Cap.	-0.84%	+0.64%	-0.59%	+15.51%

End-of-day quote OTC Bulletin Board
- ^USD	-